Skip to main content
Pediatric Oncology

Experimental models

Publication ,  Chapter
Gatz, SA; Shipley, J; Keller, C; Linardic, CM
January 1, 2021

To understand the pathophysiologic mechanisms of human bone and soft tissue sarcomas, and develop interventions to treat them, it became necessary to study sarcomas outside of the human body and deconstruct the events leading to full tumor formation. This has taken the form of human tumor-derived cell lines grown in culture, human tumor-derived cell lines and primary human tumors grown as xenografts in immunocompromised laboratory mice, genetically defined sarcoma cell lines, genetically engineered mouse models, and novel models of sarcoma arising spontaneously in domesticated animals or developed in lower organisms including zebrafish and fruit flies. This chapter reviews the uses of these approaches in understanding bone and soft tissue sarcomas and complements other recent sarcoma model reviews (O’Brien et al. 2012; Kashi et al. 2015).

Duke Scholars

DOI

Publication Date

January 1, 2021

Start / End Page

129 / 147
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gatz, S. A., Shipley, J., Keller, C., & Linardic, C. M. (2021). Experimental models. In Pediatric Oncology (pp. 129–147). https://doi.org/10.1007/978-3-030-51160-9_10
Gatz, S. A., J. Shipley, C. Keller, and C. M. Linardic. “Experimental models.” In Pediatric Oncology, 129–47, 2021. https://doi.org/10.1007/978-3-030-51160-9_10.
Gatz SA, Shipley J, Keller C, Linardic CM. Experimental models. In: Pediatric Oncology. 2021. p. 129–47.
Gatz, S. A., et al. “Experimental models.” Pediatric Oncology, 2021, pp. 129–47. Scopus, doi:10.1007/978-3-030-51160-9_10.
Gatz SA, Shipley J, Keller C, Linardic CM. Experimental models. Pediatric Oncology. 2021. p. 129–147.

DOI

Publication Date

January 1, 2021

Start / End Page

129 / 147